Home・Aktien・Medpace Holdings Inc
Search

Medpace Holdings Inc

Geschlossen

BrancheGesundheitswesen

610.11 0.7

Neutral

Kursupdate 20. Aug. 2026, 19:59 UTC

BuySell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

587.4

Max

611.03

Schlüsselkennzahlen

By Trading Economics

Einkommen

-2.5M

121M

Verkäufe

727K

707M

KGV

Branchendurchschnitt

34.005

57.371

EPS

4.25

Gewinnspanne

17.158

Angestellte

6,500

EBITDA

-21M

134M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

-1.71% downside

Dividenden

By Acuity

Nächstes Ergebnis

21. Okt. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

1.6B

17B

Vorheriger Eröffnungskurs

609.41

Vorheriger Schlusskurs

610.11

Nachrichtenstimmung

By Acuity

50%

50%

155 / 340 Ranking in Healthcare

Medpace Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Aug. 2026, 20:02 UTC

Medpace Holdings Inc. shares are higher, driven by a significant advance in the Life Sciences Tools & Services sub-sector amid a strong market session.

Lesen

17. Aug. 2026, 20:02 UTC

News

Medpace Holdings Inc. shares are higher following a Barron's report suggesting significant upside potential and robust Q2 results exceeding analyst expectations.

Lesen

14. Aug. 2026, 19:36 UTC

Medpace Holdings Inc shares are lower amid broader market sentiment following a Commerce Department report showing a decline in retail sales for July.

Lesen

13. Aug. 2026, 19:56 UTC

News

Medpace Holdings shares are lower as CEO August J. Troendle sold 23,144 shares valued at $13.98 million, raising investor concerns about future performance.

Lesen

7. Aug. 2026, 19:16 UTC

Medpace Holdings Inc. shares are lower today, reflecting a slight pullback amid broader market factors, including economic signals and geopolitical tensions.

Lesen

3. Aug. 2026, 19:26 UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

Lesen

30. Juli 2026, 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

Lesen

29. Juli 2026, 18:44 UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

Lesen

28. Juli 2026, 23:11 UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

Lesen

27. Juli 2026, 16:56 UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

Lesen

24. Juli 2026, 18:26 UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

Lesen

22. Juli 2026, 23:22 UTC

Social Media
News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

Lesen

21. Juli 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Lesen

Peer-Vergleich

Kursveränderung

Medpace Holdings Inc Prognose

Kursziel

By TipRanks

-1.71% Nachteil

12-Monats-Prognose

Durchschnitt 580.2 USD  -1.71%

Hoch 692 USD

Tief 450 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Medpace Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

11 ratings

2

Buy

9

Halten

0

Sell

Basierend auf 11 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Medpace Holdings Inc – Dist abgegeben haben.

Stimmung

By Acuity

155 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Andere Aktien aus dem Sektor

LLY

Eli Lilly and Co.

1,279.92

↑ +4.58%

JNJ

Johnson and Johnson

273.1

↑ +0.87%

ABBV

AbbVie Inc

265.68

↑ +2.62%

UNH

UnitedHealth Group Inc

388.41

↓-1.36%

MRK

Merck & Co Inc.

152.07

↑ +12.74%
help-icon Live chat